AG
ADAP

Artal Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Artal Group’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
2023
Q3 		$884K Hold
2023
Q2 		$1.05M Buy
2018
Q1 		– Sell
2017
Q4 		$4.68M Buy
2017
Q3 		$4.09M Buy
2017
Q2 		$1.35M Hold
2017
Q1 		$1.65M Hold
2016
Q4 		$1.22M Buy
2016
Q3 		$1.41M Buy